1 |
8-cyclopentyl-1,3-dipropylxanthine
| 0件: | - | - | - | 2件: 215 215, 299 |
2 |
Artesunate
| 1件: Artesunate Artesunate | 1件: D02482
D02482
| - | - | 8件: 18 18, 46, 53, 66, 96, 97, 215, 271 |
3 |
Calcium
| 2件: Calcio Calcio; Calcium | - | - | - | 30件: 3 3, 6, 13, 15, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 256, 265, 274, 298, 299 |
4 |
Calcium gluconate
| 1件: Calcium gluconate Calcium gluconate | 1件: D00935
D00935
| - | - | 3件: 214 214, 215, 235 |
5 |
Dexmedetomidine
| 4件: Dexdor Dexdor; DEXMEDETOMIDINA; DEXMEDETOMIDINE; DEXMEDETOMIDINE HYDROCHLORIDE | 2件: D00514
D00514
,
D01205
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 13件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 212, 215, 226, 280 |
6 |
Dobutamine
| 2件: Dobutamin Dobutamin; Dobutamine | 4件: D00632
D00632
,
D03879
,
D03880
,
D03881
| 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 57 57, 58, 215 |
7 |
Eplerenone
| 1件: Eplerenone Eplerenone | 1件: D01115
D01115
| 1件: NR3C2 NR3C2 💬 | 1件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | 4件: 75 75, 113, 210, 215 |
8 |
Fentanyl
| 1件: Fentanyl Fentanyl | 2件: D00320
D00320
,
D01399
| 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 4件: 46 46, 70, 215, 231 |
9 |
Flunarizine
| 0件: | 2件: D01303
D01303
,
D07971
| 3件: CACNA1G CACNA1G, CACNA1H, CACNA1I 💬 | 8件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GnRH secretion, MAPK signaling pathway, Type II diabetes mellitus 💬 | 4件: 58 58, 86, 149, 215 |
10 |
Ketamine
| 2件: Ketamine Ketamine; NMDA | 2件: D00711
D00711
,
D08098
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 8件: 2 2, 4, 6, 13, 70, 113, 156, 215 |
11 |
Losartan
| 3件: Cozaar Cozaar; Losartan; LOSARTAN POTASSIUM | 2件: D00357
D00357
,
D08146
| 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 18件: 17 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
12 |
Phenoxymethylpenicillin
| 0件: | 3件: D00497
D00497
,
D02506
,
D05411
| - | - | 3件: 13 13, 97, 215 |
13 |
Potassium
| 1件: Potassium Potassium | 1件: D08403
D08403
| - | - | 12件: 36 36, 46, 66, 67, 88, 94, 98, 115, 167, 179, 215, 235 |
14 |
Propranolol
| 3件: Propanolol Propanolol; Propranolol; Propranolol Hydrochloride | 2件: D00483
D00483
,
D08443
| 3件: ADRB1 ADRB1, ADRB2, ADRB3 💬 | 12件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 7件: 6 6, 158, 167, 215, 227, 278, 296 |
15 |
Sodium citrate
| 1件: Sodium citrate Sodium citrate | 2件: D01781
D01781
,
D05855
| - | - | 4件: 67 67, 214, 215, 235 |
16 |
Sulfur hexafluoride
| 3件: SonoVue SonoVue; SULFUR HEXAFLUORIDE; Sulphur hexafluoride | 1件: D05962
D05962
| - | - | 2件: 96 96, 215 |
17 |
Thymidine
| 1件: Thymidine Thymidine | - | - | - | 1件: 215 215 |
18 |
Tranexamic acid
| 1件: Tranexamic Acid Tranexamic Acid | 1件: D01136
D01136
| 1件: PLG PLG 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬 | 6件: 46 46, 70, 215, 227, 288, 299 |
19 |
Ubidecarenone
| 3件: Coenzyme Q-10 Coenzyme Q-10; Coenzyme Q10; CoQ10 | 1件: D01065
D01065
| - | - | 13件: 2 2, 5, 6, 8, 10, 18, 46, 57, 86, 113, 193, 214, 215 |